HOME >> BIOLOGY >> NEWS
5AM Solutions releases Microarray Enterprise Manage(TM) Software

PHOENIX, August 16, 2004-5AM Solutions, a software solution provider enabling biomedical research, today announced the release of Microarray Enterprise ManagerTM (MEM). The solution was delivered in collaboration with leading scientists from the Translational Genomics Research Institute (TGen), Duke University, and the University of California, Los Angeles. MEM is a web-based solution that manages all aspects of expression profiling laboratory workflow, data annotation, standardization, and sharing. This solution will facilitate more rapid progress in medical research by connecting researchers across the world with, and ensure they can easily combine and share, genomic data.

Sophisticated technologies from the Human Genome Project have enabled researchers to understand the basic tenets of human disease, which will eventually lead to cures. While expression microarrays are now a common genome-scale tool used widely in research, the vast amounts of data created by this technology at distant sites are rarely combined - slowing the progress of medical research. Collaboration and consortia, key elements of the National Institutes of Health (NIH) Roadmap, require sharing what and how experiments are conducted and what the results are in a meaningful way to thousands of geographically disparate scientists.

Adding to the complexity, the data must be collected, managed and distributed in a consistent manner across organizations. MEM orchestrates consistent data annotations that meet evolving industry standards for projects, samples, and the derivative microarray data.

"This solution will result in scientists being able to share data quickly and obtain real insight into human disease," said Dr. Dietrich Stephan, TGen's director of neurogenomics and Chairman of a Microarray Consortium funded by the NIH.

5AM worked with the National Institute of Neurological Disease and Stroke and the National Institute of Mental Health's Microarray
'"/>

Contact: Galen Perry
gperry@tgen.org
602-343-8423
The Translational Genomics Research Institute
16-Aug-2004


Page: 1 2

Related biology news :

1. Biotech Creates New Solutions And New Problems
2. Potential Solutions For Gulf of Mexicos "Dead Zone" Explored
3. Computer Models Find Cost-Effective Solutions For Species Preservation
4. Joslin Diabetes Center releases new low impact exercise video
5. The American Academy of Microbiology releases report
6. Academy Harbor Consortium releases letter on mercury to President Bush
7. The American Academy of Microbiology releases report
8. Journal announces scientific releases
9. ICSU releases GMO synthesis report
10. CAST releases report on environmental impacts of grazing systems on our nations resources
11. Twenty-years of long-term ecological research: National Science Foundation releases review report

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/21/2019)... ... May 20, 2019 , ... The ASGCT Clinical Trials Finder is ... throughout the United States. Data curated daily from ClinicalTrials.gov ensures the most up-to-date and ... who volunteered to assist in the development of the ASGCT Clinical Trials Finder ...
(Date:5/15/2019)... , ... May 15, 2019 , ... ... process of histology wherein tissues are cut into ultra-thin two-dimensional slices, placed on ... in the context of the brain is that the brain is a highly ...
(Date:5/8/2019)... Texas (PRWEB) , ... May ... ... Gary Hutchinson has been accepted into Forbes Technology Council, an invitation-only community ... Inc. Verified Company, is a full-service biopharmaceutical cold chain engineering firm that ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... Calif. (PRWEB) , ... April 09, 2019 , ... ... services firm focused on increasing the capacity of life sciences organizations to accelerate ... Cloud Assurance platform in the past 12 months. , USDM’s ...
(Date:4/8/2019)... ... 2019 , ... US Capital Global Securities , an affiliate of US ... the privately held pharmaceutical company, S1 Biopharma (“S1”). , S1 has a pipeline of ... sexual dysfunction disorder and is ready to begin phase 2b trials. In phase 2a ...
(Date:3/29/2019)... ... March 28, 2019 , ... Specific ... CARB-X has proceeded with a second stage of funding for Specific’s Reveal™ rapid ... is on top of the $1.7 million already awarded by CARB-X. The additional ...
(Date:3/23/2019)... , ... March 22, 2019 , ... ... collection, and analysis to a team of researchers at Nnamdi Azikiwe University in ... Dr. Nneka R. Agbokoba, PhD, of the Department of Medical Laboratory Sciences and ...
Breaking Biology Technology:
Cached News: